ReLit₹500 / month

Your literature review, before breakfast.

A weekly, AI-curated research briefing that learns your specialty, your interests, and what is actually worth your time. You can't read 10,000 papers a week — ReLit does it for you.

One email a week, on the day and time you pick · Mobile app coming soon

ReLit weekly clinical research digest

This week in your specialty

4 papers. 3 minutes. Zero noise.

CardiologyOncologyNeurologyNephrologyEndocrinologyInfectious DiseasePulmonologyPediatricsObstetrics & GynaecologyRadiologyHaematologyGastroenterologyOrthopaedicsDermatologyPsychiatryEmergency MedicineCardiologyOncologyNeurologyNephrologyEndocrinologyInfectious DiseasePulmonologyPediatricsObstetrics & GynaecologyRadiologyHaematologyGastroenterologyOrthopaedicsDermatologyPsychiatryEmergency Medicine

How it works

Three steps. Then it just shows up.

Step 1

Tell us your lane

Pick your specialty and up to three interests — from HFpEF to CAR-T. AI suggestions help you sharpen them.

Step 2

ReLit reads everything

Our pipeline scans thousands of new papers each week and keeps only what clears the clinical bar for you.

Step 3

Your schedule. Your inbox.

Pick your preferred day and time — a tight digest with one-line takeaways lands right on schedule.

Inside every digest

Not just a dump of abstracts.

Every paper is scored, badged by impact, and compressed to three "why you care" points — with key data charted when the numbers matter.

R

ReLit Weekly

Cardiology · Your pick: Fri, 6:30 AM

Sample
BREAKTHROUGHRCT · Phase III

Semaglutide vs. tirzepatide in HFpEF — head-to-head outcomes

NEJM · Aug 2026

Why you care

  • Tirzepatide cut HF hospitalizations 22% further than semaglutide
  • Renal endpoints held — safe in CKD stage 3
  • Likely changes first-line choice in obese HFpEF
HIGH IMPACTMeta-analysis

AI-assisted ECG screening reduces missed atrial fibrillation by 31%

Lancet Digital Health · Aug 2026

Why you care

  • 31% fewer missed AF cases across 14 studies
  • Biggest gain in high-volume OPD settings
  • Number needed to screen: 212

Missed AF per 1,000 screens

Usual care
31
AI-assisted
21
NOTABLEGuideline

ACC/AHA refresh on lipid management after ACS

Circulation · Aug 2026

Why you care

  • LDL target lowered to <55 mg/dL in very-high-risk patients
  • Ezetimibe add-on moved earlier in the pathway
  • Reassess everyone on statins at 4–6 weeks

10,000+

papers scanned weekly

4 min

to read your digest

1

email per week. That's it.

0

noise, or spam

Subscribe

At a price of one CME coffee.

Join the clinicians who stopped drowning in journals. Set your specialty, pick your interests and your preferred day and time — your first digest lands on schedule.

Questions? Mail us at support@jivana.org.in

Quick answers

When do I get my digest?

Whenever you want — pick your preferred day and time, and your digest lands in your inbox on schedule. And soon, ReLit becomes a full mobile app with even more features on top of the newsletter.

Can I change my specialty or interests later?

Yes. Reply to any digest or resubmit the form with the same email and your preferences update instantly.

How do I cancel?

Every digest has a one-click unsubscribe link. No emails to support, no questions asked — and we refund the unused month.

Running a study instead of reading one? Meet ReSurge →